Table 2.
Cost-Effectiveness Analysis Results for Influenza Vaccination Strategies in US Adults ≥ 65*
| Strategy | Cost | Incremental Cost | Effectiveness (QALY) | Incremental Effectiveness (QALY) | ICER |
|---|---|---|---|---|---|
| No vaccine | $96.49 | – | −0.00652 | – | – |
| IIV3 | $100.62 | $4.13 | −0.0054 | 0.00112 | $3693 |
| IIV4 | $102.64 | $2.02 | −0.0053 | 0.00010 | $20,939 |
| High-dose IIV3 | $109.10 | $6.46 | −0.0051 | 0.00021 | $31,214 |
*
Per person costs and effectiveness
QALY = quality adjusted life year, IIV3 = trivalent inactivated influenza vaccine, IIV4 = quadrivalent inactivated influenza vaccine